Lanthanide-doped upconversion nanoparticles (UCNPs) have attracted great attention in bioimaging applications. However, the stability and resolution of bioimaging based on UCNPs should be further improved. Herein, we synthesized SiO 2coated Ga(III)-doped ZnO (GZO) with lanthanide ion Yb(III) and Tm(III) (Yb/Tm/GZO@SiO 2 ) UCNPs, which realized red fluorescence imaging in heart tissue. With increasing injection concentrations of Yb/Tm/GZO@SiO 2 (1−10 mg/kg), the red fluorescence imaging intensity of heart tissue gradually increased. Moreover, the experimental results of toxicity in vitro and histological assessments of representative organs in vivo were studied, indicating that Yb/Tm/GZO@SiO 2 UCNPs had low biological toxicity. These results proved that Yb/Tm/GZO@SiO 2 can be used as a probe for fluorescence imaging in vivo.
■ INTRODUCTION
Fluorescence imaging has attracted great attention in biological applications due to its high resolution and sensitivity. 1−3 Excellent in vivo and in vitro fluorescence imaging of cells requires some key factors such as a low imaging background, high fluorescence efficiency, and good imaging of photostability. However, the excitation source of traditional fluorescence imaging is ultraviolet or visible light, which has interference from autofluorescence and strong absorption. 4, 5 It is well known that the near-infrared (NIR) region from 750 to 1000 nm is one of the "optical transmission windows". 1, 6 Fluorescence imaging in vitro and in vivo excited in the NIR light has some advantages, such as low light scattering, deep light penetration, and a high signal-to-noise ratio. 7−10 Conventional NIR chromophores are organic dyes and quantum rods (QDs). However, organic dyes have poor photostability and toxicity, which significantly limit their application in biological fluorescent probes. 11−13 Lanthanide-doped (Ln 3+ , such as Yb 3+ , Tm 3+ , Er 3+ , Ho 3+ ) upconversion nanoparticles (UCNPs) are a kind of emerging biological materials. 14−21 Upconversion luminescence (UCL) is anti-Stokes emission, which can convert to ultraviolet (UV) or visible (vis) emission via absorbing near-infrared (NIR) light. UCNPs based on their unique properties have been considered an important material for bioimaging applications. 22−28 Biological fluorescent probes based on lanthanidedoped UCNPs can be excited using 750−1000 nm NIR light. 29−33 Therefore, UCNPs show little absorption to biological components such as lipids and hemoglobin, which significantly improves deep tissue penetration and the signalto-noise ratio. 34−38 It is challenging to develop a fluorescent probe with high UCL efficiency and good stability for bioimaging in living cells. In fact, the host has an important influence on UCL properties. 39−42 An oxide host has high chemical stability and thermal stability compared to fluorides. Choosing suitable oxides with low phonon energy as the host can increase the UCL intensity and fluorescence stability. For example, zinc oxide (ZnO) has been identified as a good host candidate due to its long-term stability, low toxicity, and wide direct gap. 43−46 However, it is still a big challenge to achieve high-resolution fluorescence imaging with UCNPs. The most common interaction between UCNPs and cells has a large influence on the toxicity and cellular localization of UCNPs. It has been reported that nanoparticles usually entered the cell through endocytosis. 47, 48 The four mechanisms of endocytosis are: (i) micropinocytosis (size >1 μm), (ii) clathrin-mediated endocytosis (60 nm < size < 120 nm), (III) caveolae-mediated endocytosis (size <60 nm), and (iv) caveolae-independent endocytosis. Therefore, UCNPs can enter the cell via the coated surface on UCNPs. 49−51 Coating of UCNPs with silica shell as an effective method can improve the biocompatibility of nanoparticles. The SiO 2 shell prevents the direct interaction of UCNPs with biomolecules. Meanwhile, lanthanide ions on the surface of UCNPs show no luminescence emission, due to which these rare-earth ions are less perturbed by the degenerated crystalline fields of the host interfaces. Upon silica coating, cooperative crystalline fields are formed between the core surfaces and the coated shells, which excites the "dormant" Ln 3+ ions (nonluminance Ln 3+ ions) on the surface of nanoparticles. 52 The silica-coated surface not only improves the colloidal stability and prevents nonspecific cell uptake but also enhances the UCL efficiency. 53 Despite recent success in Yb/Tm co-doped UCNPs NIR region (about 800 nm) emission bioimaging, in vivo imaging with red emission had no establish at low pumping power due to low red UC quantum efficiency. In this work, the influence of relative concentrations of the silica coated on Yb/Tm/GZO (UCNPs) was investigated. Compared to the tetraethyl orthosilicate (TEOS)-free sample, the UCL intensity of Yb/Tm/GZO@SiO 2 increased about 13 times compared to that of Yb/Tm/ZnO UCNPs. The red UC quantum efficiency of Yb/Tm/GZO@SiO 2 was as high as 1.0 ± 0.1% under excitation with a low power density of ∼0.3 W/ cm 2 . The red UCL imaging of heart tissue treated with Yb/ Tm/GZO@SiO 2 was achieved under 980 nm excitation. With the increase of the injection concentrations of Yb/Tm/GZO@ SiO 2 , red fluorescence imaging of heart tissue gradually increased. Moreover, we proved that Yb/Tm/GZO@SiO 2 had low toxicity in vitro and in vivo.
■ RESULTS AND DISCUSSION
As shown in Scheme 1, Yb/Tm/GZO@SiO 2 core/shell nanoparticles entered the cytoplasm via endocytosis. Upon 980 nm excitation, Yb 3+ /Tm 3+ ions were excited and radiated UCL, realizing red (650 nm) light bioimaging.
Synthesis and Characterization. Yb/Tm/GZO UCNPs were synthesized by the hydrothermal method. Cit 3− served as a structure regulating the size and morphology of Yb/Tm/ GZO UCNPs. Figure 1A shows the scanning electron microscopy (SEM) images of Yb/Tm/GZO UCNPs. These Yb/Tm/GZO UCNPs exhibited structures of peony flowers and had good dispersibility. The silica coating on UCNPs can reduce the surface defects and improve the colloidal stability. Yb/Tm/GZO@SiO 2 was synthesized via the Stober method with increasing tetraethyl orthosilicate (TEOS) concentrations from 0.36 to 0.90 mL ( Figure 1B ). The transmission electron microscopy (TEM) images of Yb/Tm/GZO@SiO 2 with different TEOS concentrations are shown in Figure 1C . With 0.36 mL of TEOS, core−shell structures were not completely obtained (see Figure 1C1 ). With increasing TEOS concentrations, Yb/Tm/GZO@SiO 2 with core−shell structure was obtained, as demonstrated in Figure 1C2 −C3. The size was 63.27 ± 1.18 nm at 0.60 mL of TEOS, 12 nm larger than the core (see Figure 1D ). This result was obtained by measuring a total of 80 nanoparticles from four TEM images. With increasing TEOS up to 0.9 mL, obvious two cores were coated by the SiO 2 shell ( Figure 1C4 ). These results indicate that the core−shell structure can be controlled in Yb/Tm/ GZO@SiO 2 by varying the concentration of TEOS.
Optical Properties. The X-ray diffraction (XRD) patterns of Yb/Tm/GZO and Yb/Tm/GZO@SiO 2 are shown in Figure 2A . The diffraction peaks matched those of the hexagonal ZnO nanoparticles (JCPDs card no. . The wide diffraction peaks due to amorphous SiO 2 were not found, suggesting that the SiO 2 coating showed no change in the phase of Yb/Tm/GZO UCNPs. To determine the successful preparation of the Yb/Tm/GZO@SiO 2 core−shell structure UCNPs, characteristic functional groups of Yb/Tm/ GZO and Yb/Tm/GZO@SiO 2 were examined via Fourier transform infrared (FTIR) spectrometry. As shown in Figure  2B , the bands at 496 and 1495 cm −1 were ascribed to the Zn− O and O−H bending in the spectra of both Yb/Tm/GZO and Yb/Tm/GZO@SiO 2 , respectively. In the Yb/Tm/GZO@SiO 2 system, bands at 955 and 725 cm −1 were associated with the symmetric and asymmetric stretching vibrations of the Si−O− Si group, respectively. The bands at 2490 and 3490 cm −1 corresponded to the stretching vibrations of the Si−H and Si− O−H groups, respectively. 45 These results proved that SiO 2 was successfully coated on UCNPs. Ultraviolet−visible (UV− vis) absorption spectra of Yb/Tm/GZO and Yb/Tm/GZO@ SiO 2 were also recorded, as shown in Figure 2C . Compared to the UV−vis absorption edge of Yb/Tm/GZO UCNP, the absorption band edge of Yb/Tm/GZO@SiO 2 showed a blue shift, indicating that the energy for the 2p orbital transition of O 2− ions increased. The SiO 2 coating reduced the surface defect of Yb/Tm/GZO and thus bind free electrons transfer, which increased the energy absorbed for the electron transition in Yb/Tm/GZO@SiO 2 .
To verify the effect of SiO 2 coating on UCL intensity, the UCL spectra of Yb/Tm/GZO@SiO 2 with different TEOS contents were recorded, as shown in Figure 2D . In comparison to the TEOS-free sample, the blue and red UCL intensities had been significantly enhanced with increasing TEOS content. Particularly, when the content of TEOS was 0.60 mL, UCL intensities were about 13 times higher than that of Yb/Tm/ GZO. The red upconversion absolute quantum yield (QY) of Yb/Tm/GZO@SiO 2 was obtained by the integrating sphere to be 1.0 ± 0.1% with 0.6 mL of TEOS. This high absolute QY for red upconversion emission was achieved at a low excitation density (0.3 W/cm 2 ), indicating that Yb/Tm/GZO@SiO 2 UCNPs showed a great promising application in bioimaging. Moreover, with increasing TEOS concentration, the decay lifetimes of red UCL (650 nm) increased from 286 to 366 μs ( Figure 2E ). With increasing TEOS content, surface defects of UCNPs decreased. Meanwhile, the linear relationship between surface vibrations and SA/Vol can be represented as quenchers ([Q]) (eq 1).
When the surface defects decreased, [Q] is significantly decreased. The decay lifetime was described using the Stern−Volmer (eq 2). where τ is the decay lifetime with quenchers, τ 0 is the observed decay lifetime without quenchers, k q is the rate constant of the quencher, and τ 0 represents an ideal condition and can be regarded as a constant. The positive proportion relationship between 1/τ and [Q] shows that [Q] decreased when the decay lifetime increased. A high decay lifetime can be achieved with increasing TEOS. In addition, considering that the SiO 2 shell had an influence on the UCL intensity of UCNPs, the UCL properties of Yb/Tm/GZO@SiO 2 were investigated at different times from 0 to 25 days at room temperature. Figure  2F shows that the UCL intensities of Yb/Tm/GZO@SiO 2 had no change with the extension of times, which indicated that the SiO 2 shell greatly maintained the stability of core−shell nanoparticles.
To validate that SiO 2 coating had an effect on Yb/Tm/GZO UCL properties, the upconversion transfer mechanism of the Yb/Tm/GZO@SiO 2 core/shell system was determined. In Figure 3C , the blue UCL can be ascribed to radiative energy transfer from the 1 G 4 to 3 H 6 state of the Tm 3+ ion. The red UCL can be attributed to radiative energy transfer from the 1 G 4 to 3 F 4 state of the Tm 3+ ion. To further confirm the photon excitation process of core−shell nanoparticles, the dependence of the UCL intensity of Yb/Tm/GZO@SiO 2 nanoparticles on the power density was examined. As shown in Figure 3B , the slopes of UCL at wavelengths of 475 and 650 nm were 2.61 and 1.88, respectively. This was because the blue and red UCL emissions of Tm 3+ were attributed to the threephoton process and two-photon process, respectively. Compared to the number of photons in Yb/Tm/GZO ( Figure  S1 ), the number of photons in Yb/Tm/GZO@SiO 2 decreased. Without SiO 2 shell coating, Tm 3+ -ion-doped GZO can be excited to produce UCL emission, owing to the perturbation of the crystal field in the GZO system. Because of this, the boundary was weakly disturbed by the degenerate crystal field on the surface of GZO nanoparticles. The Tm 3+ ions near and embedded in the surface layer of the GZO host did not produce UCL emission and are called dormant ions. SiO 2 coating of Yb/Tm/GZO resulted in the interaction of the degenerated crystal field on the surface of GZO and the coordination field produced. These reduced the selection rule of radiative transitions of the dormant rare-earth ions (Yb 3+ / Tm 3+ ). The dormant ions can be activated. The excited dormant ions were called the "activated" rare-earth ions. As shown in Figure 3A (Figure 4) . The 7702 and HpG2 cell viability can be quantified using eq 3.
where A s is the absorbance of test cells with Yb/Tm/GZO@ SiO 2 nanocomposites, and A b and A c stand for the absorbance of control cells without (Yb/Tm/GZO@SiO 2 ) nanocomposites and the absorbance of blank samples containing the culture medium (without cells and (Yb/Tm/GZO@SiO 2 )), respectively. As shown in Figure 4A , the viability of 7702 cells showed no significant difference at different concentrations of 100−800 μg/mL Yb/Tm/GZO@SiO 2 for 24, 48, and 72 h. After incubating as high as 800 μg/mL of Yb/Tm/GZO@SiO 2 for 24 h, the cell viabilities were greater than 90.48%. The cell viabilities of 7702 cells kept 86.69%, despite the existence of a high concentration of 800 μg/mL and a long time of 72 h. As shown in Figure 4B , the viability of HpG2 was 99.17% after treatment of 100 μg/mL of Yb/Tm/GZO@SiO 2 for 24 h. The cellular viabilities were estimated to be greater than 99.15% with a high dosage 800 μg/mL and 72 h. These results proved that the Yb/Tm/GZO@SiO 2 core/shell had low cytotoxicity, suggesting Yb/Tm/GZO@SiO 2 as a good bioimaging probe.
In Vivo Toxicity Test of Yb/Tm/GZO@SiO 2 . To further study the in vivo toxicity of Yb/Tm/GZO@SiO 2 nanoparticles, blood biochemical indexes were examined in Kunming mouse with injecting different doses of Yb/Tm/ GZO@SiO 2 through the tail vein ( Figure 5 ). The levels of albumin (ALB), alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and cholesterol (CHOL) were related to the degree of liver cell damage, which was used as indicators to assess the function of the liver. Compared to that of control, the serum levels of ALB, ALP, ALT, AST, and CHOL had no significant change with increasing Yb/Tm/GZO@SiO 2 from 1 to 10 mg/kg ( Figure  5A −E) for 24 h and 7 days post-injection. The result of the serum aminotransferases (ALB, ALP, ALT, and AST) revealed that injection with Yb/Tm/GZO@SiO 2 nanoparticles had no obvious liver injury. As shown in Figure 5H −J, the levels of serum creatinine (CRE), uric acid (UA), and urea (UREA) were further studied to identify nephrotoxicity after treating with 1−10 mg/kg Yb/Tm/GZO@SiO 2 for 24 h and 7 days. The results showed that Yb/Tm/GZO@SiO 2 had no effect on the levels of CRE, UA, or UREA in serum, indicating that injection with Yb/Tm/GZO@SiO 2 did not cause obvious damage to the nephro. In addition, the degree of creatine kinase (CK) was used to evaluate damage to the heart. As shown in Figure 5F , even after 7 days of injection with Yb/ Tm/GZO@SiO 2 at a concentration as high as 10 mg/kg, the levels of serum CK had no obvious change compared to the control group, suggesting that Yb/Tm/GZO@SiO 2 injection had no obvious damage to the heart. Meanwhile, the levels of serum total protein (TP) were similar for the mouse injected with Yb/Tm/GZO@SiO 2 and for the control mouse ( Figure  5G ). It was proved that Yb/Tm/GZO@SiO 2 UCNPs had low toxicity in vivo, indicating their potential for biological applications.
To further determine the possible tissue toxicity, histological assessments of representative organs such as the heart, liver, kidney, and spleen were performed, as shown in Table 1 . Daily behavior of the Kuming mice, including drinking, eating, and activity, in the Yb/Tm/GZO@SiO 2 -injected groups was identical to that in the control group. As shown in Table 1 , there was no significant effect on the coefficients of the liver, kidney, and spleen 24 h after injection of Yb/Tm/GZO@SiO 2 nanoparticles. Compared to the control groups (5.01 ± 0.87 mg/g), the coefficient of the heart was slightly increased (7.09 ± 0.21 mg/g) 24 h after the tail vein injection of 10 mg/kg Yb/Tm/GZO@SiO 2 nanoparticles but without statistical significance ( a p > 0.05). The coefficients of the heart, liver, kidney, and spleen had no apparent change after 7 days of injection with Yb/Tm/GZO@SiO 2 at all dosages (1−10 mg/ kg). These results demonstrate that Yb/Tm/GZO@SiO 2 nanoparticles have low tissue toxicity and great potential applications for bioimaging.
From the analysis of tissue toxicity, we found that the coefficient of the heart was slightly increased. To assess the in vivo tissue imaging of Yb/Tm/GZO@SiO 2 nanoparticles, confocal imaging of heart tissue was studied, as shown in Figure 6 . The heart was dissected out and fresh-frozen in the optimal cutting temperature (OCT) embedding medium (Sakura Finetechnical Co., Tokyo, Japan) Sections of 10 μm were cut from frozen blocks at −20°C. Confocal imaging was done using an OLYMPUS FV500 laser scanning confocal microscope, and their upconversion luminescence was captured by channels set at 640−660 nm for receiving red upconversion emission. Figure 6 shows the multiphoton confocal imaging of heart tissue treated with 1−10 mg/kg Yb/Tm/GZO@SiO 2 following excitation at 980 nm using a femtosecond pulsed laser. The 650 nm emission (red color) of Yb/Tm/GZO@SiO 2 under 980 nm excitation was detected. Furthermore, with increasing injection concentrations of Yb/ Tm/GZO@SiO 2 , remarkably enhanced bright red luminescence was achieved, demonstrating that Yb/Tm/GZO@SiO 2 can effectively improve heart tissue imaging. These results suggested that Yb/Tm/GZO@SiO 2 nanoparticles showed excellent ability in bioimaging applications.
■ CONCLUSIONS
In summary, we demonstrated the effect of different TEOS concentrations on upconversion luminescence properties of Yb/Tm/GZO@SiO 2 . With 0.6 mL of TEOS, the UCL intensity of Yb/Tm/GZO@SiO 2 enhanced about 13 times compared to that of Yb/Tm/GZO. SiO 2 coating enhanced the All data are presented as mean ± standard error of the mean (SEM). (n = 8); a p > 0.05 versus control according to ANOVA. UCL stability and biocompatibility of Yb/Tm/GZO, which achieved red light imaging of heart tissue in vivo. In addition, the red fluorescence imaging of heart tissue gradually brightened with increasing injection concentrations of Yb/ Tm/GZO@SiO 2 from 1 to 10 mg/kg. In vitro toxicity results indicated that Yb/Tm/GZO@SiO 2 had no significant influence on the cellular viabilities of 7702 cells and HpG2 cells after 72 h incubation with Yb/Tm/GZO@SiO 2 (100− 800 μg/mL). In vivo toxicity results indicated that injection with Yb/Tm/GZO@SiO 2 nanoparticles had no obvious liver and kidney injury. The histological assessments of representative organs suggested that injection of Yb/Tm/GZO@SiO 2 nanoparticles had no significant effect on the coefficients of the heart, liver, kidney, and spleen. These studies provided that Yb/Tm/GZO@SiO 2 nanoparticles have low biotoxicity and high-resolution red tissue imaging. Synthesis of Yb/Tm/GZO. A hydrothermal method was followed: Zn(NO 3 ) 2 ·6H 2 O (0.5 mmol), deionized (DI, 10 mL) water, and Ga(NO 3 ) 3 ·xH 2 O (10 mol %) were dissolved by magnetic stirring for 30 min, and citric acid sodium was added to form a clarified liquid by magnetic stirring for 20 min. NaOH (2 mol/L, 10 mL) was added into the above clarified liquid to form a suspension solution by magnetic stirring for 30 min. Tm(NO 3 ) 3 ·5H 2 O (with 0.5 mol %, 5 mL) and Yb(NO 3 ) 3 ·5H 2 O (7 mol %, 5 mL) were added into the suspension solution by magnetic stirring for 60 min. Subsequently, the solution was transferred into a 50 mL hydrothermal reactor. The solution was heated to 150°C for 24 h. The resultant solution was cooled down and cleaned by centrifuge at 3500 rpm for 15 min with copious amounts of ethanol and DI water. Yb/Tm/GZO was obtained by oven drying at 60°C for 24 h.
Synthesis of Yb/Tm/GZO@SiO 2 . Isopropyl alcohol (40 mL) was added to Yb/Tm/GZO (0.1713 g) by ultrasonication for 30 min to form a suspension solution. DI water (10 mL) was added into the mixture by magnetic stirring for 10 min. NH 3 ·H 2 O (5 mL, 25%) was dropped into the suspension solution at 32°C by magnetic stirring for 20 min. TEOS was dropped slowly into the above solution at 32°C by magnetic stirring for 90 min. The amounts of TEOS were 0.36, 0.45, 0.60, and 0.90 mL, respectively. The resultant solution was cooled down to room temperature. The solution was washed six times with copious amounts of ethanol and DI water by centrifuge at 3500 rpm. The products were collected after oven drying at 80°C for 24 h.
Characterization. Powder X-ray diffraction (XRD) pattern measurements were performed with Cu Kα radiation (λ = 1.54 Å). Size and morphologies of UCNPs were determined at 15 kV using a focus voltage SU8000 scanning electron microscope (SEM) and at 200 kV using a focus voltage JEOL 2010F transmission electron microscope (TEM). The upconversion emission spectra of the nanoparticles were measured at 980 nm excitation. A signal generator was used to convert a continuous 980 nm excitation source to a pulse excitation source. The upconversion spectra of samples used 980 nm as the excitation source. The excitation density was 0.3 W/cm 2 . The excitation source was focused on the sample through a convex lens and became an upconversion luminous source. The source point was the sample output upconversion fluorescence. The upconversion fluorescence was absorbed by a photomultiplier tube through a set of lenses. The photomultiplier tube type was CR131, which could reach the test compensation of 1 nm, expand the light signal, and then pass through. When the receiver receives the signal and transmits the data to the connected computer, the upconversion fluorescence spectrum of a certain band would appear on the computer.
The decay lifetime of the sample was obtained on a computer with a 980 nm laser, MD03024 Mixed Domain Oscilloscope. The excitation density was 0.3 W/cm 2 . The integrating sphere was used to obtain the QY of UCNPs.
Cytotoxicity Assay. The normal human hepatic cell line (7702) and the human HpG2 were cultured in the RPMI 1640 medium containing 10% fetal bovine serum. The normal human hepatic cell line (7702) and the human HpG2 were cultured in RPMI 1640 (HyClone, Thermo Fisher, Beijing, China) medium containing 10% fetal bovine serum and 1% penicillin−streptomycin. Cells were maintained in a humidified incubator (Thermo Forma) containing 5% CO 2 at 37°C, and all of the experiments were performed in a clean atmosphere. A CCK8 kit (Beyotime, Shanghai, China) was used for cell viability assay. A total of 5 × 10 3 cells/well were seeded into 96-well plates and incubated at 37°C for 24 h. Yb/Tm/ GZO@SiO 2 in the RPMI 1640/DMEM medium was added at final concentrations of 100, 200, 400, 600, and 800 μg/mL. At the end of the fixed incubation period (24, 48 , and 72 h), 10 μL of the CCK8 reagent was added to each well and incubated for 4 h at 37°C. The absorbance was recorded using a panwavelength microplate reader at 450 nm (Synergy Mx; BioTek, Winooski, VT). Each experiment was performed in triplicate. The cell viability can be quantified using the following equation.
where A s is the absorbance of the test sample (test wells containing cells, culture medium, and samples), A b is the absorbance of the control sample (control wells containing cells and culture medium without samples), and A c is the absorbance of blank samples (blank wells containing the culture medium without cell and samples).
In Vivo Toxicity and Imaging Studies. All animal experiments and procedures were approved by the Animal Ethical and Experimental Committee of the Tianjin Medical University Metabolic Diseases Hospital. Five-week-old male Kunming mice (23−26 g) were purchased from the animal center of Military Medical Sciences Academy of the PLA (Permission no SCXK-(A) 2012-0004). All experimental mice were maintained in a 12 h light/12 h dark cycle at 22°C and 55 ± 5% relative humidity in a standard laboratory room at Tianjin Medical University (Tianjin, China). The mice were provided rodent chow and water ad libitum.
After a week of acclimation, the mice were randomly allocated into four groups (eight animals in each group): three sample groups (treated with final doses 1, 6, and 10 mg/kg of the Yb/Tm/GZO@SiO 2 body weight) and a vehicle group (treated with an equivalent volume of phosphate-buffered saline (PBS)). Yb/Tm/GZO@SiO 2 nanoparticles and PBS were injected via the tail vein. Eight mice from each group were weighed and sacrificed by CO 2 asphyxiation after 24 h and 7 days. Serum samples were collected by centrifugation (3000g, 10 min). ALB, ALP, ALT, AST, CHOL, CK, TP, CRE, UA, and UREA were detected according to the kit's protocol (Roche, People's Republic of China). Liver, lung, spleen, kidney, and heart samples were collected and weighed. The heart was dissected out and fresh-frozen in the OCT embedding medium (Sakura Finetechnical Co, Tokyo, Japan). Sections of 10 μm were cut from frozen blocks at −20°C, and confocal microscopy was used to observe the imaging of cardiac myocytes. Confocal imaging was done using an OLYMPUS FV500 laser scanning confocal microscope (120 × 10 oil lens), and their upconversion luminescence was captured by channels set at 640−660 nm for receiving red upconversion emission at 980 nm using a femtosecond pulsed laser under an excitation of 0.3 W/cm 2 .
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